tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF

RepliCel Life Sciences (REPCF) Financial Statements

22 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently ―. The company's EPS TTM is $0.004; its P/E ratio is 9.33; RepliCel Life Sciences is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total RevenueC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43K
Gross ProfitC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43KC$ 88.43K
EBITC$ -127.53KC$ 2.22MC$ -385.78KC$ -558.51KC$ -963.37K
EBITDAC$ -118.55KC$ 2.23MC$ -385.78KC$ -539.62KC$ -954.43K
Net Income Common StockholdersC$ -251.83KC$ 2.03MC$ -818.60KC$ -558.51KC$ -963.37K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 16.64KC$ 76.41KC$ 32.48KC$ 232.77KC$ 697.26K
Total AssetsC$ 202.53KC$ 287.79KC$ 331.46KC$ 495.65KC$ 1.08M
Total DebtC$ 60.82KC$ 60.00KC$ 40.96KC$ 40.96KC$ 40.96K
Net DebtC$ 44.18KC$ -16.41KC$ 8.48KC$ -191.81KC$ -656.31K
Total LiabilitiesC$ 4.99MC$ 4.82MC$ 6.97MC$ 6.55MC$ 6.55M
Stockholders EquityC$ -4.78MC$ -4.53MC$ -6.64MC$ -6.05MC$ -5.47M
Cash Flow-
Free Cash FlowC$ -160.13KC$ 337.49K-C$ -1.55MC$ -1.12M
Operating Cash FlowC$ -160.13KC$ 337.49K-C$ -1.55MC$ -1.12M
Investing Cash FlowC$ 17.25K----
Financing Cash FlowC$ 100.36KC$ -293.56K-C$ 1.35MC$ 1.40M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

RepliCel Life Sciences Debt to Assets

RepliCel Life Sciences Cash Flow

RepliCel Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis